Chia Tai Enterprises International Limited (HKG:3839)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotech Business	535.91M	307.75M	173.98M	159.24M	142.41M
Biotech Business Growth	74.14%	76.89%	9.26%	11.82%	52.18%
Total	535.91M	307.75M	173.98M	159.24M	142.41M
Total Growth	74.14%	76.89%	9.26%	11.82%	52.18%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	421.31M	233.23M	107.95M	83.29M	70.47M
Mainland China Growth	80.64%	116.05%	29.60%	18.20%	91.89%
Americas	44.16M	32.12M	24.65M	29.10M	30.65M
Americas Growth	37.51%	30.30%	-15.30%	-5.07%	78.12%
Asia Pacific (Excluding Mainland China)	47.33M	27.38M	28.73M	24.35M	27.11M
Asia Pacific (Excluding Mainland China) Growth	72.91%	-4.70%	17.95%	-10.17%	-3.95%
Europe and Elsewhere	23.11M	15.03M	-	-	-
Europe and Elsewhere Growth	53.80%	-	-	-	-
Europe	-	-	5.16M	16.43M	7.62M
Europe Growth	-	-	-68.61%	115.53%	-4.51%
Elsewhere	-	-	7.50M	6.06M	6.56M
Elsewhere Growth	-	-	23.72%	-7.54%	90.80%
Total	535.91M	307.75M	173.98M	159.24M	142.41M
Total Growth	74.14%	76.89%	9.26%	11.82%	52.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error